Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

CXCL13 antibody for the treatment of autoimmune disorders.

Klimatcheva E, Pandina T, Reilly C, Torno S, Bussler H, Scrivens M, Jonason A, Mallow C, Doherty M, Paris M, Smith ES, Zauderer M.

BMC Immunol. 2015 Feb 12;16:6. doi: 10.1186/s12865-015-0068-1.

2.

Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease.

Southwell AL, Franciosi S, Villanueva EB, Xie Y, Winter LA, Veeraraghavan J, Jonason A, Felczak B, Zhang W, Kovalik V, Waltl S, Hall G, Pouladi MA, Smith ES, Bowers WJ, Zauderer M, Hayden MR.

Neurobiol Dis. 2015 Apr;76:46-56. doi: 10.1016/j.nbd.2015.01.002. Epub 2015 Feb 3.

3.

Nonclinical Safety Evaluation of VX15/2503, a Humanized IgG4 Anti-SEMA4D Antibody.

Leonard JE, Fisher TL, Winter LA, Cornelius CA, Reilly C, Smith ES, Zauderer M.

Mol Cancer Ther. 2015 Apr;14(4):964-72. doi: 10.1158/1535-7163.MCT-14-0924. Epub 2015 Feb 5.

PMID:
25657333
4.

Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.

Evans EE, Jonason AS Jr, Bussler H, Torno S, Veeraraghavan J, Reilly C, Doherty MA, Seils J, Winter LA, Mallow C, Kirk R, Howell A, Giralico S, Scrivens M, Klimatcheva K, Fisher TL, Bowers WJ, Paris M, Smith ES, Zauderer M.

Cancer Immunol Res. 2015 Jun;3(6):689-701. doi: 10.1158/2326-6066.CIR-14-0171. Epub 2015 Jan 22.

PMID:
25614511
5.

SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.

Smith ES, Jonason A, Reilly C, Veeraraghavan J, Fisher T, Doherty M, Klimatcheva E, Mallow C, Cornelius C, Leonard JE, Marchi N, Janigro D, Argaw AT, Pham T, Seils J, Bussler H, Torno S, Kirk R, Howell A, Evans EE, Paris M, Bowers WJ, John G, Zauderer M.

Neurobiol Dis. 2014 Oct 18;73C:254-268. doi: 10.1016/j.nbd.2014.10.008. [Epub ahead of print]

6.

Anti-CXCL13 antibody can inhibit the formation of gastric lymphoid follicles induced by Helicobacter infection.

Yamamoto K, Nishiumi S, Yang L, Klimatcheva E, Pandina T, Takahashi S, Matsui H, Nakamura M, Zauderer M, Yoshida M, Azuma T.

Mucosal Immunol. 2014 Sep;7(5):1244-54. doi: 10.1038/mi.2014.14. Epub 2014 Mar 19.

PMID:
24646940
7.
8.

Clinal patterns of desiccation and starvation resistance in ancestral and invading populations of Drosophila subobscura.

Gilchrist GW, Jeffers LM, West B, Folk DG, Suess J, Huey RB.

Evol Appl. 2008 Aug;1(3):513-23. doi: 10.1111/j.1752-4571.2008.00040.x.

9.

C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer.

Evans EE, Henn AD, Jonason A, Paris MJ, Schiffhauer LM, Borrello MA, Smith ES, Sahasrabudhe DM, Zauderer M.

Mol Cancer Ther. 2006 Nov;5(11):2919-30.

10.

Construction of cDNA libraries in vaccinia virus.

Smith ES, Shi S, Zauderer M.

Methods Mol Biol. 2004;269:65-76. Review.

PMID:
15114008
11.

Lethality-based selection of recombinant genes in mammalian cells: application to identifying tumor antigens.

Smith ES, Mandokhot A, Evans EE, Mueller L, Borrello MA, Sahasrabudhe DM, Zauderer M.

Nat Med. 2001 Aug;7(8):967-72.

PMID:
11479631
12.

The relationship of CD5+ B lymphocytes to macrophages: insights from normal biphenotypic B/macrophage cells.

Borrello MA, Palis J, Phipps RP.

Int Rev Immunol. 2001 Feb;20(1):137-55. Review.

PMID:
11342302
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk